Non-Invasive Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.%li%
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
This report contains market size and forecasts of Non-Invasive Cancer Diagnostics in Global, including the following market information:
Global Non-Invasive Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Invasive Cancer Diagnostics market was valued at 111670 million in 2021 and is projected to reach US$ 144320 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CTCs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Cancer Diagnostics include Gen-Probe Inc, Digene Corporation, Quest Diagnostics Inc, Cancer, Genetics Inc, BIOVIEW Inc, AVIVA Biosciences Corporation, Laboratory Corporation of America Holdings (LabCorp), A&G Pharmaceutical and Affymetrix Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Invasive Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
This report contains market size and forecasts of Non-Invasive Cancer Diagnostics in Global, including the following market information:
Global Non-Invasive Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Invasive Cancer Diagnostics market was valued at 111670 million in 2021 and is projected to reach US$ 144320 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CTCs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Cancer Diagnostics include Gen-Probe Inc, Digene Corporation, Quest Diagnostics Inc, Cancer, Genetics Inc, BIOVIEW Inc, AVIVA Biosciences Corporation, Laboratory Corporation of America Holdings (LabCorp), A&G Pharmaceutical and Affymetrix Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
- CTCs
- CTNAS
- Exosomes
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Blood
- Urine
- Saliva
Global Non-Invasive Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Invasive Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gen-Probe Inc
- Digene Corporation
- Quest Diagnostics Inc
- Cancer, Genetics Inc
- BIOVIEW Inc
- AVIVA Biosciences Corporation
- Laboratory Corporation of America Holdings (LabCorp)
- A&G Pharmaceutical
- Affymetrix Inc
- Precision Therapeutics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Non-Invasive Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-INVASIVE CANCER DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Non-Invasive Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Non-Invasive Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Non-Invasive Cancer Diagnostics Players in Global Market
3.2 Top Global Non-Invasive Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Non-Invasive Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Invasive Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Non-Invasive Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Non-Invasive Cancer Diagnostics Market Size Markets, 2021 & 2028
4.1.2 CTCs
4.1.3 CTNAS
4.1.4 Exosomes
4.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-Invasive Cancer Diagnostics Market Size, 2021 & 2028
5.1.2 Blood
5.1.3 Urine
5.1.4 Saliva
5.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-Invasive Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.3.2 US Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.3.3 Canada Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.3.4 Mexico Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.4.2 Germany Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.3 France Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.4 U.K. Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.5 Italy Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.6 Russia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.8 Benelux Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.5.2 China Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.3 Japan Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.4 South Korea Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.6 India Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.6.2 Brazil Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.6.3 Argentina Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.7.2 Turkey Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.3 Israel Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.5 UAE Non-Invasive Cancer Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Gen-Probe Inc
7.1.1 Gen-Probe Inc Corporate Summary
7.1.2 Gen-Probe Inc Business Overview
7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Gen-Probe Inc Key News
7.2 Digene Corporation
7.2.1 Digene Corporation Corporate Summary
7.2.2 Digene Corporation Business Overview
7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Digene Corporation Key News
7.3 Quest Diagnostics Inc
7.3.1 Quest Diagnostics Inc Corporate Summary
7.3.2 Quest Diagnostics Inc Business Overview
7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Quest Diagnostics Inc Key News
7.4 Cancer, Genetics Inc
7.4.1 Cancer, Genetics Inc Corporate Summary
7.4.2 Cancer, Genetics Inc Business Overview
7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Cancer, Genetics Inc Key News
7.5 BIOVIEW Inc
7.5.1 BIOVIEW Inc Corporate Summary
7.5.2 BIOVIEW Inc Business Overview
7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.5.5 BIOVIEW Inc Key News
7.6 AVIVA Biosciences Corporation
7.6.1 AVIVA Biosciences Corporation Corporate Summary
7.6.2 AVIVA Biosciences Corporation Business Overview
7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.6.5 AVIVA Biosciences Corporation Key News
7.7 Laboratory Corporation of America Holdings (LabCorp)
7.7.1 Laboratory Corporation of America Holdings (LabCorp) Corporate Summary
7.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Laboratory Corporation of America Holdings (LabCorp) Key News
7.8 A&G Pharmaceutical
7.8.1 A&G Pharmaceutical Corporate Summary
7.8.2 A&G Pharmaceutical Business Overview
7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Major Product Offerings
7.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.8.5 A&G Pharmaceutical Key News
7.9 Affymetrix Inc
7.9.1 Affymetrix Inc Corporate Summary
7.9.2 Affymetrix Inc Business Overview
7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Affymetrix Inc Key News
7.10 Precision Therapeutics
7.10.1 Precision Therapeutics Corporate Summary
7.10.2 Precision Therapeutics Business Overview
7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Major Product Offerings
7.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Precision Therapeutics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Non-Invasive Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-INVASIVE CANCER DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Non-Invasive Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Non-Invasive Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Non-Invasive Cancer Diagnostics Players in Global Market
3.2 Top Global Non-Invasive Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Non-Invasive Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Invasive Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Non-Invasive Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Non-Invasive Cancer Diagnostics Market Size Markets, 2021 & 2028
4.1.2 CTCs
4.1.3 CTNAS
4.1.4 Exosomes
4.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-Invasive Cancer Diagnostics Market Size, 2021 & 2028
5.1.2 Blood
5.1.3 Urine
5.1.4 Saliva
5.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-Invasive Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.3.2 US Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.3.3 Canada Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.3.4 Mexico Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.4.2 Germany Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.3 France Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.4 U.K. Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.5 Italy Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.6 Russia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.4.8 Benelux Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.5.2 China Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.3 Japan Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.4 South Korea Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.5.6 India Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.6.2 Brazil Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.6.3 Argentina Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, 2017-2028
6.7.2 Turkey Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.3 Israel Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Non-Invasive Cancer Diagnostics Market Size, 2017-2028
6.7.5 UAE Non-Invasive Cancer Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Gen-Probe Inc
7.1.1 Gen-Probe Inc Corporate Summary
7.1.2 Gen-Probe Inc Business Overview
7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Gen-Probe Inc Key News
7.2 Digene Corporation
7.2.1 Digene Corporation Corporate Summary
7.2.2 Digene Corporation Business Overview
7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Digene Corporation Key News
7.3 Quest Diagnostics Inc
7.3.1 Quest Diagnostics Inc Corporate Summary
7.3.2 Quest Diagnostics Inc Business Overview
7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Quest Diagnostics Inc Key News
7.4 Cancer, Genetics Inc
7.4.1 Cancer, Genetics Inc Corporate Summary
7.4.2 Cancer, Genetics Inc Business Overview
7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Cancer, Genetics Inc Key News
7.5 BIOVIEW Inc
7.5.1 BIOVIEW Inc Corporate Summary
7.5.2 BIOVIEW Inc Business Overview
7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.5.5 BIOVIEW Inc Key News
7.6 AVIVA Biosciences Corporation
7.6.1 AVIVA Biosciences Corporation Corporate Summary
7.6.2 AVIVA Biosciences Corporation Business Overview
7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.6.5 AVIVA Biosciences Corporation Key News
7.7 Laboratory Corporation of America Holdings (LabCorp)
7.7.1 Laboratory Corporation of America Holdings (LabCorp) Corporate Summary
7.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Laboratory Corporation of America Holdings (LabCorp) Key News
7.8 A&G Pharmaceutical
7.8.1 A&G Pharmaceutical Corporate Summary
7.8.2 A&G Pharmaceutical Business Overview
7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Major Product Offerings
7.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.8.5 A&G Pharmaceutical Key News
7.9 Affymetrix Inc
7.9.1 Affymetrix Inc Corporate Summary
7.9.2 Affymetrix Inc Business Overview
7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Affymetrix Inc Key News
7.10 Precision Therapeutics
7.10.1 Precision Therapeutics Corporate Summary
7.10.2 Precision Therapeutics Business Overview
7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Major Product Offerings
7.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Precision Therapeutics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Non-Invasive Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Non-Invasive Cancer Diagnostics Market Drivers in Global Market
Table 3. Non-Invasive Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Non-Invasive Cancer Diagnostics in Global Market
Table 5. Top Non-Invasive Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Invasive Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Invasive Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Invasive Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Non-Invasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Invasive Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Invasive Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Gen-Probe Inc Corporate Summary
Table 31. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 32. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Digene Corporation Corporate Summary
Table 34. Digene Corporation Non-Invasive Cancer Diagnostics Product Offerings
Table 35. Digene Corporation Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Quest Diagnostics Inc Corporate Summary
Table 37. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 38. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Cancer, Genetics Inc Corporate Summary
Table 40. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 41. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. BIOVIEW Inc Corporate Summary
Table 43. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 44. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. AVIVA Biosciences Corporation Corporate Summary
Table 46. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offerings
Table 47. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Laboratory Corporation of America Holdings (LabCorp) Corporate Summary
Table 49. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offerings
Table 50. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. A&G Pharmaceutical Corporate Summary
Table 52. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offerings
Table 53. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Affymetrix Inc Corporate Summary
Table 55. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 56. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Precision Therapeutics Corporate Summary
Table 58. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offerings
Table 59. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 1. Non-Invasive Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Non-Invasive Cancer Diagnostics Market Drivers in Global Market
Table 3. Non-Invasive Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Non-Invasive Cancer Diagnostics in Global Market
Table 5. Top Non-Invasive Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Invasive Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Invasive Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Invasive Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Non-Invasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Invasive Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Invasive Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Invasive Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Gen-Probe Inc Corporate Summary
Table 31. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 32. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Digene Corporation Corporate Summary
Table 34. Digene Corporation Non-Invasive Cancer Diagnostics Product Offerings
Table 35. Digene Corporation Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Quest Diagnostics Inc Corporate Summary
Table 37. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 38. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Cancer, Genetics Inc Corporate Summary
Table 40. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 41. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. BIOVIEW Inc Corporate Summary
Table 43. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 44. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. AVIVA Biosciences Corporation Corporate Summary
Table 46. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offerings
Table 47. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Laboratory Corporation of America Holdings (LabCorp) Corporate Summary
Table 49. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offerings
Table 50. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. A&G Pharmaceutical Corporate Summary
Table 52. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offerings
Table 53. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Affymetrix Inc Corporate Summary
Table 55. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offerings
Table 56. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Precision Therapeutics Corporate Summary
Table 58. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offerings
Table 59. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Non-Invasive Cancer Diagnostics Segment by Type in 2021
Figure 2. Non-Invasive Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Non-Invasive Cancer Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Non-Invasive Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Invasive Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Digene Corporation Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Non-Invasive Cancer Diagnostics Segment by Type in 2021
Figure 2. Non-Invasive Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Non-Invasive Cancer Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Non-Invasive Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Invasive Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Invasive Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Digene Corporation Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
